Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 949 Official Publication of Indian Association of Medical Microbiologists 
  Search
 
 ~ Next article
 ~ Previous article 
 ~ Table of Contents
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (185 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
 ~  References

 Article Access Statistics
    Viewed4106    
    Printed284    
    Emailed3    
    PDF Downloaded760    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 


 
EDITORIAL
Year : 2010  |  Volume : 28  |  Issue : 4  |  Page : 275-276
 

New Delhi metallo-beta-lactamase 1: Is there a need to worry?


Editor, IJMM, A/3 No 38-Labourdinnaise Street, Pondicherry - 605 006, India

Date of Submission15-Sep-2010
Date of Acceptance15-Sep-2010
Date of Web Publication20-Oct-2010

Correspondence Address:
Reba Kanungo
Editor, IJMM, A/3 No 38-Labourdinnaise Street, Pondicherry - 605 006
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0255-0857.71800

Rights and Permissions



How to cite this article:
Kanungo R. New Delhi metallo-beta-lactamase 1: Is there a need to worry?. Indian J Med Microbiol 2010;28:275-6

How to cite this URL:
Kanungo R. New Delhi metallo-beta-lactamase 1: Is there a need to worry?. Indian J Med Microbiol [serial online] 2010 [cited 2020 Jul 12];28:275-6. Available from: http://www.ijmm.org/text.asp?2010/28/4/275/71800


Outrage and outcry aside, a recent report of New Delhi metallo-β-lactamase (NDM-1) drives home the concern of rapidly increasing antibiotic resistance among bacteria encountered in hospitals.

Rhetoric and blame games apart, countries cannot be singled out for the spread of resistant strains. It has been seen globally that clonal spread of resistant organisms occurs in the best of health care settings in many countries. Emergence and spread of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enteroccocus (VRE), penicillinase-producing  Neisseria More Details gonorrhea (PPNG), and penicillin-resistant Streptococcus pneumoniae (PRSP) are examples of some organisms that have spread across countries. Globalization, rapid travel, and vanishing borders may have helped the organisms find a safe haven to travel via the human body. Studies conducted on the international spread of multiresistant PPNG detected in the 1960s in the SE Asia region show that it has now become a problem in the western hemisphere. [1]

Several international and national medical and allied journals publish reports on the alarming rise of antibiotic resistance both in the hospital and the community. Basic research at the molecular level and new techniques to study genetic mechanisms facilitate detection of hither to unknown genes and plasmids. Studies on prevalence of resistance, risk factors in hospitals and community, vertical and horizontal transmission of antibiotic resistance are regularly published. This year more than 25 scientific articles dealing with antibiotic resistance have been published in the Indian Journal of Medical Microbiology alone. There have been several other articles and reviews published in these issues on infection control, hand washing, biomedical waste disposal, and antibiotic policy. All of these emphasize ways and means to contain infection. Uncontrolled infection and irrational use of antibiotics in the hospital is closely related to the emergence of resistant strains. It is a matter of concern that despite increasing reports of antimicrobial resistance, little effort is made to validate the results and translate the findings into practice.

A concerted effort is required at individual, institutional, and national level to stop the rising trend of antibiotic resistance. Guest editorial in the July (2010) issue of the Indian Journal of Medical Microbiology carried a very apt article on "National Antibiotic Resistance Surveillance and Control. [2] The author has outlined action points for instituting guidelines for antibiotic policy by "a mechanism to monitor the changing pattern of antibiotic resistance and regulate antibiotic dispensation necessary to halt the rising trend." [2] It is also understood that with best of efforts, hospital infection could still persist albeit at very negligible levels.

Clinical microbiologists have a significant role to play in controlling emergence of multi-drug-resistant bacteria. It is believed that a proactive approach to reporting susceptibility pattern of organisms will help clinicians use appropriate antibiotics. Unlike the west, there is still a long way to go, for clinical microbiologists in India, to be decisive members of the treatment team. However, a beginning must be made. Microbiologists must step out of the laboratories to play an active role in patient care. Auditing of antibiotic reports along with evaluating the impact of the report on treatment policy in the hospital could perhaps be a first step toward an integration of laboratory and clinical practice.

A "super bug" is first detected and documented in the laboratory. The onus therefore is on the clinical microbiologist to improve laboratory standards, establish quality control measures, and use appropriate methods for reproducible results. Standardized techniques for susceptibility testing must include recommended media, antibiotic disks and powders, appropriate temperatures and duration of incubation, and accurate interpretation of the results. [3]

Some laboratories have now incorporated routine screening of MRSA and ESBL and detection of other resistant markers in their daily laboratory procedures. Other clinical laboratories may find this an extra load on manpower and resources. However, implication of these tests on rational treatment cannot be overemphasized.

Simple cost-effective methods recommended in the Clinical Laboratory Standards Institute guidelines are available for routine testing. [3] The quality of reporting must be improved for client satisfaction. To cite an example when reporting an MRSA, a line may be added on which group or class of antibiotics are to be avoided. The same holds true for a beta-lactamase or carbapenamase producers.

In the absence of extra screening tests for the enzymes and other markers, a clinical microbiologist must be able to correlate group/class resistance to interpret susceptibility patterns rationally. In addition, frequent updating of current resistance patterns of common bacteria will help rationalize use of antibiotics. In the absence of a hospital infection control committee, the microbiology department can take up leadership in updating their clinical colleagues on the current status. The article on "The hospital antibiogram: A necessity" by Joshi, in the current issue, highlights some of the methods a laboratory can adopt to disseminate information on resistance pattern. [4] Quality laboratory data must be made available in real time to influence standard treatment guidelines. [1] These guidelines can be developed for each institute based on the surveillance of antibiotic resistance patterns.

Prevention and containment of antimicrobial resistance has been outlined in a monograph by WHO SEARO, on regional strategy on guiding principles. The key principles are (a) to understand the emergence and spread of resistance; (b) to rationalize the use of available antimicrobials (this is useful for public sector hospitals where dispensation of antibiotics is subsidized or free of cost to the patient); (c) reduction of selection pressure by infection control practice; (d) to change the behavioral pattern in prescribing and rational prescription; (e) to promote discovery, development, and delivery of new drugs and tools; and (f) national coordination with defined functions of different sectors and programs. [1] These are practical and easy to follow guidelines, which can be adopted by concerned players in the health care sector.

There is an urgent need to change the mindset of, and create awareness among all health care providers, policy makers, and administrators to the dangers of emerging antibiotic resistance. National and regional guidelines and policies must not only be made but also implemented and monitored to combat antibiotic resistance and contain emergence of "super bugs."

 
 ~ References Top

1.WHO SEARO: Regional strategy on prevention and containment of antimicrobial resistance 2010-2015. WHO, regional office for SE Asia: 2010.  Back to cited text no. 1      
2.Raghunath D. National antibiotic resistance surveillance and control. Indian J Med Microbiol 2010;28:189-90.  Back to cited text no. 2  [PUBMED]  Medknow Journal  
3.Clinical and Laboratory Standards Institute (CLSI). Analysis and presentation of cumulative antimicrobial susceptibility test data. 3rd ed. Approved guideline M39-A3. Wayne PA: CLSI; 2009.  Back to cited text no. 3      
4.Joshi S. The hospital antibiogram: A necessity. Indian J Med Microbiol 2010;28:277.  Back to cited text no. 4    Medknow Journal  



This article has been cited by
1 Emergence of New Delhi metallo--lactamase type 1-producing Enterobacteriaceae and non-Enterobacteriaceae: global case detection and bacterial surveillance
Greta Bushnell,Fanny Mitrani-Gold,Linda M. Mundy
International Journal of Infectious Diseases. 2013; 17(5): e325
[Pubmed] | [DOI]
2 Zinc-dependent carbapenemases in clinical isolates of family Enterobacteriaceae
Rai, S., Manchanda, V., Singh, N.P., Kaur, I.R.
Indian Journal of Medical Microbiology. 2011; 29(3): 275-279
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04